Androgen Receptor
Also written as AR.
DHT is 10x more potent than testosterone in binding androgen receptors.
What our notes say
- DHT is 10x more potent than testosterone in binding androgen receptors. (Male Reproductive System Pathology)
- DHT is 10x more potent than testosterone in binding androgen receptors (Penile & Testicular Pathologies: Hypospadias, Tumors, Torsion – Male Reproductiv)
- Androgen receptor (AR) signalling drives growth throughout the disease course, including castration-resistant stage (Female & Male Genital Pathology: Ulcers, HPV, Endometriosis, Pre-eclampsia)
- DHT (from testosterone via 5-alpha-reductase type 2) binds nuclear androgen receptors → promotes growth (Quick Guide: Male Reproductive System Pathology, Testis, Penis)
- | SBMA | LMN weakness · diminished androgen | Androgen receptor (polyglutamine) | Androgen receptor | (Neurodegenerative Prion Diseases: CJD, Pathology & Rapid Dementia)
- Antiandrogens: Bicalutamide, Enzalutamide — block androgen receptor. (Cancer Pharmacology: Cell Cycle, Oncogenes & Drug Targets)